GUGGENHEIM CAPITAL LLC - HEMISPHERX BIOPHARMA INC ownership

HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 22 filers reported holding HEMISPHERX BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q1 2018$8,000
+14.3%
19,614
+0.6%
0.00%
Q4 2017$7,0000.0%19,495
-11.1%
0.00%
Q3 2017$7,000
+16.7%
21,929
+71.6%
0.00%
Q2 2017$6,000
-14.3%
12,7800.0%0.00%
Q1 2017$7,00012,7800.00%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Occidental Asset Management, LLC 15,834$5,0000.00%
TWO SIGMA SECURITIES, LLC 79,881$28,0000.00%
Waldron Private Wealth LLC 11,000$3,0000.00%
Virtu Financial LLC 61,278$21,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 80$00.00%
Sound Income Strategies, LLC 9$00.00%
Creative Planning 40,001$14,0000.00%
CITY HOLDING CO 417$00.00%
WELLS FARGO & COMPANY/MN 20,000$7,0000.00%
NORTHERN TRUST CORP 31,933$11,0000.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders